How do you choose an initial biologic for a patient with allergic type 2 severe asthma who plans pregnancy within 6–12 months?

Anti-IgE has the most reassuring pregnancy registry experience but anti–IL-4Rα or anti-TSLP may offer greater expected symptom/exacerbation gains.